vs
Side-by-side financial comparison of B&G Foods, Inc. (BGS) and Bio-Techne (TECH). Click either name above to swap in a different company.
B&G Foods, Inc. is the larger business by last-quarter revenue ($439.3M vs $295.9M, roughly 1.5× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs -4.4%, a 17.2% gap on every dollar of revenue. On growth, B&G Foods, Inc. posted the faster year-over-year revenue change (-4.7% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -12.8%).
B&G Foods, Inc. is an American branded foods holding company based in Parsippany, New Jersey. The company was formed in 1996 to acquire Bloch & Guggenheimer, a Manhattan-based producer of pickles, relish and condiments which had been founded in 1889.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
BGS vs TECH — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $439.3M | $295.9M |
| Net Profit | $-19.1M | $38.0M |
| Gross Margin | 22.5% | 64.6% |
| Operating Margin | 2.5% | 18.4% |
| Net Margin | -4.4% | 12.8% |
| Revenue YoY | -4.7% | -6.4% |
| Net Profit YoY | -356.5% | 68.3% |
| EPS (diluted) | $-0.24 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $295.9M | ||
| Q3 25 | $439.3M | — | ||
| Q2 25 | $424.4M | $317.0M | ||
| Q1 25 | $425.4M | $316.2M | ||
| Q4 24 | $551.6M | $297.0M | ||
| Q3 24 | $461.1M | $289.5M | ||
| Q2 24 | $444.6M | $306.1M | ||
| Q1 24 | $475.2M | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $-19.1M | — | ||
| Q2 25 | $-9.8M | $-17.7M | ||
| Q1 25 | $835.0K | $22.6M | ||
| Q4 24 | $-222.4M | $34.9M | ||
| Q3 24 | $7.5M | $33.6M | ||
| Q2 24 | $3.9M | $40.6M | ||
| Q1 24 | $-40.2M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | 22.5% | — | ||
| Q2 25 | 20.5% | 62.7% | ||
| Q1 25 | 21.2% | 67.9% | ||
| Q4 24 | 21.5% | 65.3% | ||
| Q3 24 | 22.2% | 63.2% | ||
| Q2 24 | 20.7% | 66.4% | ||
| Q1 24 | 22.9% | 67.4% |
| Q4 25 | — | 18.4% | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 5.2% | -7.5% | ||
| Q1 25 | 8.4% | 12.2% | ||
| Q4 24 | -46.6% | 16.0% | ||
| Q3 24 | 11.1% | 13.8% | ||
| Q2 24 | 9.9% | 15.0% | ||
| Q1 24 | -3.3% | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | -4.4% | — | ||
| Q2 25 | -2.3% | -5.6% | ||
| Q1 25 | 0.2% | 7.1% | ||
| Q4 24 | -40.3% | 11.7% | ||
| Q3 24 | 1.6% | 11.6% | ||
| Q2 24 | 0.9% | 13.3% | ||
| Q1 24 | -8.5% | 16.2% |
| Q4 25 | — | $0.24 | ||
| Q3 25 | $-0.24 | — | ||
| Q2 25 | $-0.12 | $-0.11 | ||
| Q1 25 | $0.01 | $0.14 | ||
| Q4 24 | $-2.81 | $0.22 | ||
| Q3 24 | $0.09 | $0.21 | ||
| Q2 24 | $0.05 | $0.26 | ||
| Q1 24 | $-0.51 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.9M | $172.9M |
| Total DebtLower is stronger | $2.0B | $260.0M |
| Stockholders' EquityBook value | $470.7M | $2.0B |
| Total Assets | $2.9B | $2.5B |
| Debt / EquityLower = less leverage | 4.30× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | $60.9M | — | ||
| Q2 25 | $54.1M | $162.2M | ||
| Q1 25 | $61.2M | $140.7M | ||
| Q4 24 | $50.6M | $177.5M | ||
| Q3 24 | $54.7M | $187.5M | ||
| Q2 24 | $40.3M | $152.9M | ||
| Q1 24 | $42.5M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.0B | $346.0M | ||
| Q1 25 | $2.0B | $330.0M | ||
| Q4 24 | $2.0B | $300.0M | ||
| Q3 24 | $2.1B | $300.0M | ||
| Q2 24 | $2.0B | $319.0M | ||
| Q1 24 | $2.0B | $389.0M |
| Q4 25 | — | $2.0B | ||
| Q3 25 | $470.7M | — | ||
| Q2 25 | $501.4M | $1.9B | ||
| Q1 25 | $513.1M | $2.0B | ||
| Q4 24 | $524.8M | $2.1B | ||
| Q3 24 | $755.3M | $2.1B | ||
| Q2 24 | $765.0M | $2.1B | ||
| Q1 24 | $781.2M | $2.0B |
| Q4 25 | — | $2.5B | ||
| Q3 25 | $2.9B | — | ||
| Q2 25 | $2.9B | $2.6B | ||
| Q1 25 | $3.0B | $2.6B | ||
| Q4 24 | $3.0B | $2.7B | ||
| Q3 24 | $3.4B | $2.7B | ||
| Q2 24 | $3.4B | $2.7B | ||
| Q1 24 | $3.4B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | 4.30× | — | ||
| Q2 25 | 3.97× | 0.18× | ||
| Q1 25 | 3.91× | 0.16× | ||
| Q4 24 | 3.85× | 0.14× | ||
| Q3 24 | 2.75× | 0.14× | ||
| Q2 24 | 2.67× | 0.15× | ||
| Q1 24 | 2.61× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-64.6M | — |
| Free Cash FlowOCF − Capex | $-70.7M | — |
| FCF MarginFCF / Revenue | -16.1% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $54.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $-64.6M | — | ||
| Q2 25 | $17.8M | $98.2M | ||
| Q1 25 | $52.7M | $41.1M | ||
| Q4 24 | $80.3M | $84.3M | ||
| Q3 24 | $4.2M | $63.9M | ||
| Q2 24 | $11.3M | $75.5M | ||
| Q1 24 | $35.1M | $81.0M |
| Q4 25 | — | — | ||
| Q3 25 | $-70.7M | — | ||
| Q2 25 | $11.5M | $93.3M | ||
| Q1 25 | $42.4M | $31.0M | ||
| Q4 24 | $71.7M | $77.5M | ||
| Q3 24 | $-679.0K | $54.7M | ||
| Q2 24 | $5.2M | $57.5M | ||
| Q1 24 | $27.5M | $64.5M |
| Q4 25 | — | — | ||
| Q3 25 | -16.1% | — | ||
| Q2 25 | 2.7% | 29.4% | ||
| Q1 25 | 10.0% | 9.8% | ||
| Q4 24 | 13.0% | 26.1% | ||
| Q3 24 | -0.1% | 18.9% | ||
| Q2 24 | 1.2% | 18.8% | ||
| Q1 24 | 5.8% | 21.3% |
| Q4 25 | — | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.5% | 1.5% | ||
| Q1 25 | 2.4% | 3.2% | ||
| Q4 24 | 1.6% | 2.3% | ||
| Q3 24 | 1.0% | 3.2% | ||
| Q2 24 | 1.4% | 5.9% | ||
| Q1 24 | 1.6% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 63.17× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | 0.56× | 1.90× | ||
| Q2 24 | 2.87× | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BGS
| Specialty Segment | $150.5M | 34% |
| Meals Segment | $110.0M | 25% |
| Spices And Flavor Solutions Segment | $101.4M | 23% |
| Frozen And Vegetables Segment | $77.4M | 18% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
